Susquehanna Fundamental Investments’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-107,894
Closed -$630K 1058
2025
Q1
$630K Sell
107,894
-9,102
-8% -$48K 0.01% 793
2024
Q4
$435K Buy
+116,996
New +$540K 0.01% 880
2024
Q2
$998K Buy
118,574
+18,458
+18% +$197K 0.02% 556
2024
Q1
$1.45M Buy
+100,116
New +$1.66M 0.07% 280
2022
Q4
Sell
-35,226
Closed -$1.64M 1541
2022
Q3
$1.64M Buy
+35,226
New +$1.63M 0.03% 646
2022
Q1
$5.54M Buy
76,624
+22,826
+42% +$1.65M 0.11% 265
2021
Q4
$4.36M Buy
53,798
+2,410
+5% +$242K 0.11% 226
2021
Q3
$5.98M Buy
51,388
+49,988
+3,571% +$6.54M 0.11% 249
2021
Q2
$232K Buy
+1,400
New +$219K ﹤0.01% 1441

Other funds holding NVRO

Susquehanna Fundamental Investments's NVRO Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 107,894 shares — an estimated $630K sold.

Susquehanna Fundamental Investments first reported a position in NVRO in Q2 2021 and held it in 9 quarters. The position peaked at $5.98M in Q3 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 107,894 NEVRO CORP. shares in Q2 2025, an estimated $630K.
  • Susquehanna Fundamental Investments first reported a position in NEVRO CORP. in Q2 2021 and held it in 9 quarters.
  • Susquehanna Fundamental Investments's NEVRO CORP. position peaked at $5.98M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.